| is selling at 27 organic growth you have |
6.08 |
Jump to 5.12 |
|
|
| that are unassailable that no one |
5.68 |
Jump to 11.2 |
|
|
| name in icare any one of these should be |
4.8 |
Jump to 16.88 |
|
|
| a premium multiple and you traded six |
3.519 |
Jump to 19.84 |
|
|
| comments in may of 2016 when i joined |
4.16 |
Jump to 27.76 |
|
|
| correct fit and that was like 30 plus |
3.36 |
Jump to 35.84 |
|
|
| billion dollars you said i had multiple |
3.359 |
Jump to 37.52 |
|
|
| investigations over the past five years |
4.16 |
Jump to 39.2 |
|
|
| that debt i brought the debt down by 10 |
4.48 |
Jump to 43.36 |
|
|
| billion dollars but but there's still |
4.08 |
Jump to 45.28 |
|
|
| further number two we've resolved the |
3.519 |
Jump to 49.36 |
|
|
| number three and most importantly we |
4.241 |
Jump to 54.879 |
|
|
| into three great companies that's what |
4.96 |
Jump to 66.4 |
|
|
| threshold today and over the next 30 to |
4.481 |
Jump to 73.119 |
|
|
| 60 days to unlock these companies we're |
3.84 |
Jump to 75.52 |
|
|
| it was 27 year-to-date growth and of |
4.72 |
Jump to 132.08 |
|
|
| pharmaceutical company so we have three |
4.56 |
Jump to 140.0 |
|
|
| don't miss a second of mad money follow |
6.08 |
Jump to 144.56 |
|
|
| 1-800-743-cnbc |
3.0 |
Jump to 159.84 |
|
|